KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Humana (HUM) EBITDA (2016 - 2025)

Humana has reported EBITDA over the past 17 years, most recently at -$622.0 million for Q4 2025.

  • Quarterly results put EBITDA at -$622.0 million for Q4 2025, down 96.21% from a year ago — trailing twelve months through Dec 2025 was $3.5 billion (changed 0.2% YoY), and the annual figure for FY2025 was $3.5 billion, changed 0.2%.
  • EBITDA for Q4 2025 was -$622.0 million at Humana, down from $591.0 million in the prior quarter.
  • Over the last five years, EBITDA for HUM hit a ceiling of $3.1 billion in Q4 2021 and a floor of -$622.0 million in Q4 2025.
  • Median EBITDA over the past 5 years was $1.4 billion (2021), compared with a mean of $1.2 billion.
  • Biggest five-year swings in EBITDA: surged 72.34% in 2022 and later tumbled 151.59% in 2024.
  • Humana's EBITDA stood at $3.1 billion in 2021, then crashed by 89.74% to $318.0 million in 2022, then plummeted by 139.62% to -$126.0 million in 2023, then tumbled by 151.59% to -$317.0 million in 2024, then tumbled by 96.21% to -$622.0 million in 2025.
  • The last three reported values for EBITDA were -$622.0 million (Q4 2025), $591.0 million (Q3 2025), and $1.3 billion (Q2 2025) per Business Quant data.